Cointime

MacuLogix

company

About

MacuLogix focuses on detecting and tracking age-related macular degeneration.

  • 51 - 100

Highlights

Total Funding Amount
$10M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
$10M
Industries
Health Care,Health Diagnostics,Therapeutics
Founded date
Jan 1, 2004
Number Of Employee
51 - 100
Operating Status
Active

MacuLogix focuses on detecting and tracking age-related macular degeneration. It leverages the science of dark adaptation to help eliminate preventable blindness caused by AMD. Through its AdaptDx® dark adaptometer, MacuLogix enables eye care professionals to detect, monitor, and start treating AMD three years before it can be seen in order to prevent vision loss.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$10M
MacuLogix has raised a total of $10M in funding over 2 rounds. Their latest funding was raised on Jul 18, 2018 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 18, 2018 Debt Financing $10M 1 Horizon Technology Finance — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
MacuLogix is funded by 1 investors. Horizon Technology Finance are the most recent investors.
Investor Name Lead Investor Funding Round
Horizon Technology Finance Yes Debt Financing
Cointime
Содержание
компания